Middle East and Africa Neurovascular Devices Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product (Neurothrombectomy Devices, Aneurysm Coiling & Embolization Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices); Application (Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas, and Other Applications); End User (Hospitals, Ambulatory Surgical Centers, and Specialized Clinics) and Country

No. of Pages: 98    |    Report Code: TIPRE00016223    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East and Africa Neurovascular Devices Market

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Middle East and Africa Neurovascular Devices Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Middle East and Africa Neurovascular Devices Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing Incidences of Neurovascular Diseases
  • 5.1.2 Rising Demand for Minimally Invasive Procedures
  • 5.1.3 Significantly Growing Aging Population
5.2 Market Opportunities
  • 5.2.1 Development in the Healthcare Market
  • 5.2.2 Lack of Expert Professionals
5.3 Future Trends
  • 5.3.1 Enduring Clinical Trials for the Treatment of Stroke
5.4 Impact of Drivers and Restraints

6. Middle East and Africa Neurovascular Devices Market Regional Analysis

6.1 Middle East and Africa Neurovascular Devices Market Overview
6.2 Middle East and Africa Neurovascular Devices Market Revenue 2017-2027 (US$ Million)
6.3 Middle East and Africa Neurovascular Devices Market Forecast Analysis

7. Middle East and Africa Neurovascular Devices Market Analysis – by Product

7.1 Neurothrombectomy Devices
  • 7.1.1 Overview
  • 7.1.2 Neurothrombectomy Devices: Middle East and Africa Neurovascular Devices Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Aneurysm Coiling & Embolization Devices
  • 7.2.1 Overview
  • 7.2.2 Aneurysm Coiling & Embolization Devices: Middle East and Africa Neurovascular Devices Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Cerebral Balloon Angioplasty & Stenting Systems and Support Devices
  • 7.3.1 Overview
  • 7.3.2 Cerebral Balloon Angioplasty & Stenting Systems and Support Devices: Middle East and Africa Neurovascular Devices Market – Revenue and Forecast to 2031 (US$ Million)

8. Middle East and Africa Neurovascular Devices Market Analysis – by Application

8.1 Cerebral Aneurysms
  • 8.1.1 Overview
  • 8.1.2 Cerebral Aneurysms: Middle East and Africa Neurovascular Devices Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Ischemic Strokes
  • 8.2.1 Overview
  • 8.2.2 Ischemic Strokes: Middle East and Africa Neurovascular Devices Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Arteriovenous Malformation & Fistulas
  • 8.3.1 Overview
  • 8.3.2 Arteriovenous Malformation & Fistulas: Middle East and Africa Neurovascular Devices Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Other Applications
  • 8.4.1 Overview
  • 8.4.2 Other Applications: Middle East and Africa Neurovascular Devices Market – Revenue and Forecast to 2027 (US$ Million)

9. Middle East and Africa Neurovascular Devices Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Other Applications: Middle East and Africa Neurovascular Devices Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Ambulatory Surgical Centers
  • 9.2.1 Overview
  • 9.2.2 Other Applications: Middle East and Africa Neurovascular Devices Market – Revenue and Forecast to 2027 (US$ Million)
9.3 Specialized Clinics
  • 9.3.1 Overview
  • 9.3.2 Other Applications: Middle East and Africa Neurovascular Devices Market – Revenue and Forecast to 2027 (US$ Million)

10. Middle East and Africa Neurovascular Devices Market – Middle East and Africa Analysis

10.1 Middle East and Africa
  • 10.1.1 Middle East and Africa Neurovascular Devices Market Breakdown, by Key Country, 2020 and 2027 (%)
  • 10.1.1.1 Middle East and Africa Neurovascular Devices Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 South Africa: Middle East and Africa Neurovascular Devices Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.1.1 South Africa: Middle East and Africa Neurovascular Devices Market Breakdown, by Product
    • 10.1.1.1.2 South Africa: Middle East and Africa Neurovascular Devices Market Breakdown, by Application
    • 10.1.1.1.3 South Africa: Middle East and Africa Neurovascular Devices Market Breakdown, by End User
  • 10.1.1.2 Saudi Arabia: Middle East and Africa Neurovascular Devices Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.2.1 Saudi Arabia: Middle East and Africa Neurovascular Devices Market Breakdown, by Product
    • 10.1.1.2.2 Saudi Arabia: Middle East and Africa Neurovascular Devices Market Breakdown, by Application
    • 10.1.1.2.3 Saudi Arabia: Middle East and Africa Neurovascular Devices Market Breakdown, by End User
  • 10.1.1.3 UAE: Middle East and Africa Neurovascular Devices Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.3.1 UAE: Middle East and Africa Neurovascular Devices Market Breakdown, by Product
    • 10.1.1.3.2 UAE: Middle East and Africa Neurovascular Devices Market Breakdown, by Application
    • 10.1.1.3.3 UAE: Middle East and Africa Neurovascular Devices Market Breakdown, by End User
  • 10.1.1.4 Rest of Middle East and Africa: Middle East and Africa Neurovascular Devices Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.4.1 Rest of Middle East and Africa: Middle East and Africa Neurovascular Devices Market Breakdown, by Product
    • 10.1.1.4.2 Rest of Middle East and Africa: Middle East and Africa Neurovascular Devices Market Breakdown, by Application
    • 10.1.1.4.3 Rest of Middle East and Africa: Middle East and Africa Neurovascular Devices Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Middle East and Africa Neurovascular Devices Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Medtronic plc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Johnson and Johnson, Inc (DePuy Synthes)
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Penumbra, Inc
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Terumo Corporation
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Acandis GmbH & Co. KG
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - M Market

  1. Medtronic plc
  2. Johnson and Johnson, Inc (DePuy Synthes)
  3. Penumbra, Inc
  4. Terumo Corporation
  5. Acandis GmbH & Co. KG